Attached files
| file | filename |
|---|---|
| 10-K - 10-K FY20 - Harpoon Therapeutics, Inc. | harp-10k_20201231.htm |
| EX-32.1 - EX-32.1 - Harpoon Therapeutics, Inc. | harp-ex321_9.htm |
| EX-31.2 - EX-31.2 - Harpoon Therapeutics, Inc. | harp-ex312_14.htm |
| EX-31.1 - EX-31.1 - Harpoon Therapeutics, Inc. | harp-ex311_8.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements of Harpoon Therapeutics, Inc.:
|
|
• |
Registration Statement on Form S-8 (No. 333-229592) pertaining to the Harpoon Therapeutics, Inc. 2015 Equity Incentive Plan, 2019 Equity Incentive Plan and 2019 Employee Stock Purchase Plan; |
|
|
• |
Registration Statement on Form S-8 (No. 333-237173) pertaining to the Harpoon Therapeutics, Inc. 2019 Equity Incentive Plan and 2019 Employee Stock Purchase Plan; and |
|
|
• |
Registration Statement on Form S-3 (No. 333-237175) of Harpoon Therapeutics, Inc. |
of our report dated March 10, 2021 with respect to the financial statements of Harpoon Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Redwood City, California
March 10, 2021